Jan B. Vermorken

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

Jan B. Vermorken, Fernando Rivera, Éva Remenár et al. · New England Journal of Medicine · 2008 · 3.7K citations · Full text

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy

Jan B. Vermorken, José Trigo, Ricardo Hitt et al. · Journal of Clinical Oncology · 2007 · 996 citations · Full text

Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck

G. Catimel, Jaap Verweij, Vera Mattijssen et al. · Annals of Oncology · 1994 · 258 citations

Active Drug, Medicine, Pharmacotherapy +7

Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck

J. Bernier, James A. Bonner, Jan B. Vermorken et al. · Annals of Oncology · 2007 · 217 citations · Full text

Radiation Therapy, Squamous Cell Carcinoma, Radiation Dermatitis +8

Long-term survival in ovarian cancer

J.P. Neijt, W.W. ten Bokkel Huinink, M.E.L. van der Burg et al. · European Journal of Cancer and Clinical Oncology · 1991 · 213 citations

Medicine, Gynecology, Cancer Treatment +5